Daily Insight into Hong Kong Stocks: DeepSeek Secures $50 Billion Funding, Yum China Acquires Full Ownership of Pizza Hut in Mainland China

Stock News07:55

Today's key focus is on the accelerated pace of A-share IPO expansion in the second quarter, which is benefiting the entire investment banking and investment chain of Chinese securities firms. Data from the Shanghai Stock Exchange shows new A-share accounts in May reached 2.7653 million, a year-on-year increase of 77.76% and a month-on-month rise of 11%. As of June 12th, the average daily stock trading volume for 2026 has accumulated to 3.20 trillion yuan, up 98.4% year-on-year. The total IPO fundraising scale for April and May combined reached 32.3 billion yuan, a 25% increase compared to the 25.9 billion yuan for the entire first quarter. The accelerated IPO expansion in Q2 is benefiting the entire investment banking and investment chain of brokerages.

Financial industry insiders point out that the valuation of the securities sector is currently at a low level, with the industry's annual and first-quarter reports meeting expectations. Full-year profitability is expected to continue recovering. Luo Zuanhui, chief non-banking financial analyst at Shenwan Hongyuan, noted that since August 2025, due to factors like capital flows, the sector's performance has diverged from market trading activity, and its valuation has deviated from its earnings performance, placing it in a quadrant of "high ROE, low PB," highlighting its investment appeal. Kaiyuan Securities released a research report stating that the pressure on capital markets in the second quarter is expected to ease, with follow-on financing deals finalized. The IPO expansion benefits the high-profit growth of brokerages' investment banking and investment chains. Brokerage performance in Q2 is anticipated to continue exceeding expectations, with attention on the sustained improvement of ROE driven by three long-term narratives: the historical wealth management opportunity under deposit migration, overseas balance sheet expansion driven by cross-border demand, and the launch of investment banking and investment businesses amid the technology wave. Market catalysts to watch include capital market conditions and interim report previews.

Market Outlook

SpaceX's market capitalization has risen to $2.65 trillion. Overnight in U.S. markets, the Dow Jones Industrial Average closed up 328.64 points at 51,999.67, a gain of 0.64%. The S&P 500 index fell 42.94 points to 7,511.35, a decline of 0.57%. The Nasdaq Composite dropped 307.6 points to 26,376.34, down 1.15%. Major tech stocks were broadly lower, with Marvell Technology down over 9%, Intel falling more than 8%, and AMD declining over 7%. SpaceX surged over 17% intraday before paring gains to close up 4.83%. Its market cap reached $2.65 trillion, surpassing Amazon by approximately $8 billion. Optical communication concept stocks were mostly lower, with Applied Optoelectronics down over 10% and Lumentum falling more than 8%. Most popular Chinese concept stocks declined, with the Nasdaq Golden Dragon China Index dropping 2.5%. The Hong Kong Hang Seng Index ADRs rose, with the proportional calculation indicating a close at 24,612.41 points, up 118.46 points or 0.48% from Hong Kong's close. The front-month WTI crude oil futures contract on the New York Mercantile Exchange fell $4.13 to $76.62 per barrel, a drop of 5.11%. The front-month COMEX gold futures contract rose $1.40, or 0.03%, to $4,353.0 per ounce.

Key Developments to Monitor

DeepSeek has finalized a 50 billion yuan funding round, valuing the company at 338 billion yuan. On June 16th, multiple media reports indicated that DeepSeek completed its first external funding round since its founding, raising over 50 billion yuan (approximately $7.4 billion), setting a record for the largest single financing round in China's AI industry. Post-funding, the company's valuation is approximately 338 billion yuan (around $50 billion), placing it among the highest-valued AI companies domestically. The investor lineup includes Liang Wenfeng himself contributing 20 billion yuan as the largest investor; Tencent investing 10 billion yuan; Contemporary Amperex Technology Co. Limited (CATL) contributing 5 billion yuan; JD.com, NetEase, and IDG Capital each investing 3 billion yuan; and the National Artificial Intelligence Industry Investment Fund investing 1 billion yuan. This diverse group spans internet giants, industrial capital, and well-known investment institutions, reflecting broad recognition of DeepSeek's technical capabilities and commercial prospects from leading entities across different sectors.

YUM CHINA (ASX: 09987) has acquired full ownership of the Pizza Hut brand in mainland China. On June 16th, Yum China Holdings, Inc. (NYSE: YUMC, HKEX: 09987), China's largest restaurant group, announced it has signed a definitive agreement with Yum! Brands, Inc. to acquire the ownership of the Pizza Hut brand in mainland China for a cash consideration of $1.2 billion.

The Australian Mining and Energy Union stated that U.S. coal producer Peabody Energy has implemented a two-week lockout of workers at its United Wambo coal preparation plant in New South Wales, escalating a wage dispute. The union indicated that workers have been taking protected industrial action since early May after rejecting a proposal that included a 2.5% annual salary increase and adjustments to bonus arrangements. This development involves Hong Kong-listed coal stocks such as Yancoal Australia Ltd (03668), Yanzhou Coal Mining Co Ltd (01171), Mongolian Mining Corporation (00975), China Coal Energy Company Limited (01898), China Shenhua Energy Company Limited (01088), Inner Mongolia Yitai Coal Co Ltd (03948), E-Commodities Holdings Ltd (01733), and China Shenhua Energy Company Limited (01088).

IntelliCentrics (Hong Kong) Limited (ASX: 01159) announced it has commenced satellite in-orbit payload verification services and plans to complete its first in-orbit intelligent verification mission by the end of the year. The company stated that since June 2026, it has begun offering satellite in-orbit payload verification services and has signed multiple agreements with partners. The focus covers businesses related to AI computing power payloads, ground demonstration system construction, and in-orbit measurement, control, and operations. The group plans to complete its first in-orbit intelligent verification mission by the end of 2026 and advance joint development of AI satellites, targeting a satellite launch mission by mid-2027.

A subsidiary of Grande Holdings Limited (ASX: 00565) plans to invest HK$7.634 million in a Busan hyperscale data center project and provide a loan of $8.986 million with an annual interest rate of 15%. The target company plans to develop and position the project as a hyperscale data center in Busan, with a contracted power capacity of 270,000 kVA (equivalent to approximately 200 MW), primarily targeting core clients such as global cloud service providers, AI companies, and large internet and technology firms. Subject to the fulfillment of certain conditions outlined in the letters of intent: (i) Hyundai Asset Management Co., Ltd and SV Investment Corporation have expressed interest in acquiring shares in the target company for a consideration of not less than 60 billion Korean won (approximately HK$300 million); (ii) Mirae Asset Securities Co., Ltd and Consus Asset Management Co., Ltd are willing to provide the target company with funds of approximately HK$5 billion and HK$1.8 billion, respectively, to support the project; and (iii) LG CNS intends to participate in the design, construction, and operation of the data center infrastructure and lease approximately 20% of the site for operations upon project completion.

Esssex Bio-Technology Ltd (ASX: 01061) and Shanghai Henlius Biotech, Inc. announced that the Phase III clinical study for the co-developed licensed product AURA-2, treating exudative (wet) age-related macular degeneration, met its primary endpoint. The primary endpoint of the study was the mean change in Best Corrected Visual Acuity (BCVA) from baseline at week 36. Key secondary endpoints included the mean change in BCVA from baseline at week 48, with other secondary endpoints covering efficacy, safety, tolerability, and pharmacokinetic indicators. Study results showed that the mean change in BCVA from baseline at both week 36 and week 48 in the HLX04-O group was non-inferior to the ranibizumab group, meeting both the primary and key secondary endpoints. Furthermore, HLX04-O demonstrated a similar overall, ocular, and non-ocular safety profile to ranibizumab in wet AMD patients, with good safety.

Luye Pharma Group Ltd (ASX: 02186) announced positive results from the Chinese Phase II clinical study of its innovative drug LY03015 (a VMAT2 inhibitor/Sigma-1R agonist) for treating Tardive Dyskinesia (TD). The company stated that the Phase II clinical trial in China for its self-developed Class 1 innovative drug LY03015 for treating TD has been completed, achieving positive results and meeting the primary endpoint. LY03015 is the world's first dual-target innovative drug (targeting Vesicular Monoamine Transporter 2 and Sigma-1 Receptor) to enter clinical trials, with target indications being TD and chorea associated with Huntington's Disease (HD).

Lopal Tech Co., Ltd. (ASX: 02465) plans a share placement at a discount of approximately 8.91% to raise up to about HK$194 million net. The company entered into a placing agreement with joint placing agents to issue up to a total of 15 million placing shares at HK$13.09 per share, representing a discount of approximately 8.91% to the closing price of HK$14.37 per H share on the day.

New Stock Grey Market | SENASIC (Jiangsu) Co., Ltd. (ASX: 06675) closed up 72% in grey market trading, generating a profit of HK$2,644 per board lot. The company, dubbed the "first stock of Physical AI edge-side wireless intelligent chips," is scheduled to list in Hong Kong on Wednesday, June 17th. As of the close, grey market trading showed a quoted price of HK$31.58, a 72% increase from the offer price of HK$18.36. With each board lot consisting of 200 shares, and excluding handling fees, the profit per lot is HK$2,644.

Featured Stock Analysis

Tianli Holdings Group Limited (ASX: 00117): The MLCC shortage may persist beyond 2027. Channel sources indicate that the current MLCC shortage is not limited to specifications used in AI; major specification products are also in tight supply. This MLCC shortage is expected to continue until 2027 or even 2028, potentially surpassing the passive component shortage wave of 2018. Tianli Holdings Group is primarily an investment holding company engaged in the ceramic capacitor business. Its 2025 annual report showed MLCC revenue of 639 million yuan last year, with gross profit margin increasing to 21.2%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment